Published in Ophthalmic Res on February 03, 2010
Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis. Hum Mutat (2004) 3.07
BBS10 encodes a vertebrate-specific chaperonin-like protein and is a major BBS locus. Nat Genet (2006) 2.68
Identification of a novel BBS gene (BBS12) highlights the major role of a vertebrate-specific branch of chaperonin-related proteins in Bardet-Biedl syndrome. Am J Hum Genet (2006) 2.44
Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin. Hum Mol Genet (2003) 2.37
Retinal dehydrogenase 12 (RDH12) mutations in leber congenital amaurosis. Am J Hum Genet (2004) 1.78
Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion. Am J Ophthalmol (2004) 1.74
Glucagon-like peptide-1 is involved in sodium and water homeostasis in humans. Digestion (2006) 1.53
Characterization of pupil responses to blue and red light stimuli in autosomal dominant retinitis pigmentosa due to NR2E3 mutation. Invest Ophthalmol Vis Sci (2012) 1.50
Nasal epithelial cells are a reliable source to study splicing variants in Usher syndrome. Hum Mutat (2010) 1.48
Molecular and in silico analyses of the full-length isoform of usherin identify new pathogenic alleles in Usher type II patients. Hum Mutat (2007) 1.48
Enrichment of LOVD-USHbases with 152 USH2A genotypes defines an extensive mutational spectrum and highlights missense hotspots. Hum Mutat (2014) 1.45
Comprehensive survey of mutations in RP2 and RPGR in patients affected with distinct retinal dystrophies: genotype-phenotype correlations and impact on genetic counseling. Hum Mutat (2007) 1.44
Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus. J Infect Dis (2010) 1.43
Extensive macular atrophy with pseudodrusen-like appearance: a new clinical entity. Am J Ophthalmol (2009) 1.38
Usher syndrome type 2 caused by activation of an USH2A pseudoexon: implications for diagnosis and therapy. Hum Mutat (2011) 1.36
Mitochondrial dynamics and disease, OPA1. Biochim Biophys Acta (2006) 1.35
Mutations in NMNAT1 cause Leber congenital amaurosis with early-onset severe macular and optic atrophy. Nat Genet (2012) 1.33
Effects of OPA1 mutations on mitochondrial morphology and apoptosis: relevance to ADOA pathogenesis. J Cell Physiol (2007) 1.30
Testing for triallelism: analysis of six BBS genes in a Bardet-Biedl syndrome family cohort. Eur J Hum Genet (2005) 1.28
Mutations in CNNM4 cause recessive cone-rod dystrophy with amelogenesis imperfecta. Am J Hum Genet (2009) 1.28
Risk factors for complications after congenital cataract surgery without intraocular lens implantation in the first 18 months of life. Am J Ophthalmol (2008) 1.27
OPA1 functions in mitochondria and dysfunctions in optic nerve. Int J Biochem Cell Biol (2009) 1.19
Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells. PLoS Pathog (2013) 1.18
OPA1 R445H mutation in optic atrophy associated with sensorineural deafness. Ann Neurol (2005) 1.18
Non-USH2A mutations in USH2 patients. Hum Mutat (2012) 1.17
The ABCA4 gene in autosomal recessive cone-rod dystrophies. Am J Hum Genet (2002) 1.12
Dominant optic atrophy. Orphanet J Rare Dis (2012) 1.11
Four-year follow-up of diagnostic service in USH1 patients. Invest Ophthalmol Vis Sci (2011) 1.03
Fourteen novel OPA1 mutations in autosomal dominant optic atrophy including two de novo mutations in sporadic optic atrophy. Hum Mutat (2003) 0.99
Cellular immune response in the presence of protective antibody levels correlates with protection against 1918 influenza in ferrets. Vaccine (2011) 0.98
Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein. Virology (2006) 0.97
Incidence of posterior vitreous detachment after cataract surgery. J Cataract Refract Surg (2009) 0.97
Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis). Eur J Ophthalmol (2010) 0.96
Mutations in IMPG1 cause vitelliform macular dystrophies. Am J Hum Genet (2013) 0.96
Identification of three novel OA1 gene mutations identified in three families misdiagnosed with congenital nystagmus and carrier status determination by real-time quantitative PCR assay. BMC Genet (2003) 0.95
Reactivation of toxoplasma retinochoroiditis under atovaquone therapy in an immunocompetent patient. Ocul Immunol Inflamm (2006) 0.95
Reversible optic neuropathy with OPA1 exon 5b mutation. Ann Neurol (2008) 0.93
High prevalence of resistance to APC in young patients with retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol (2002) 0.93
Novel mutations in MYO7A and USH2A in Usher syndrome. Ophthalmic Genet (2005) 0.92
Subretinal hemorrhages associated with age-related macular degeneration in patients receiving anticoagulation or antiplatelet therapy. Am J Ophthalmol (2009) 0.92
Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion. Ophthalmologica (2014) 0.90
RP1 and autosomal dominant rod-cone dystrophy: novel mutations, a review of published variants, and genotype-phenotype correlation. Hum Mutat (2011) 0.90
Homozygous mutation in MERTK causes severe autosomal recessive retinitis pigmentosa. Eur J Ophthalmol (2012) 0.90
Characterization of Ca2+ signalling in postnatal mouse retinal ganglion cells: involvement of OPA1 in Ca2+ clearance. Ophthalmic Genet (2010) 0.90
Combining gene mapping and phenotype assessment for fast mutation finding in non-consanguineous autosomal recessive retinitis pigmentosa families. Eur J Hum Genet (2011) 0.87
Retinal vascular occlusions: an interdisciplinary challenge. Dtsch Arztebl Int (2008) 0.87
Relative frequencies of inherited retinal dystrophies and optic neuropathies in Southern France: assessment of 21-year data management. Ophthalmic Epidemiol (2013) 0.86
Should transcobalamin deficiency be treated aggressively? J Inherit Metab Dis (2010) 0.86
Recurrent retinal vein occlusion in a patient with increased plasma levels of histidine-rich glycoprotein. Am J Ophthalmol (2003) 0.86
Homozygosity mapping in autosomal recessive retinitis pigmentosa families detects novel mutations. Mol Vis (2013) 0.85
Molecular diagnosis reveals genetic heterogeneity for the overlapping MKKS and BBS phenotypes. Eur J Med Genet (2010) 0.85
The ocular anomalies in a cystinosis animal model mimic disease pathogenesis. Pediatr Res (2007) 0.84
Mosaic synaptopathy and functional defects in Cav1.4 heterozygous mice and human carriers of CSNB2. Hum Mol Genet (2013) 0.84
Sensorineural hearing loss in OPA1-linked disorders. Brain (2013) 0.84
Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells. Invest Ophthalmol Vis Sci (2002) 0.83
Assessment of construct validity of a virtual reality laparoscopy simulator. J Laparoendosc Adv Surg Tech A (2007) 0.83
Mutational analysis of the RB1 gene in Moroccan patients with retinoblastoma. Mol Vis (2011) 0.82
Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium. Bull Mem Acad R Med Belg (2006) 0.82
Optical coherence tomography for diagnosis of posterior vitreous detachment at the macular region. Eur J Ophthalmol (2009) 0.81
Selective thrombophilia screening of patients with nonarteritic anterior ischemic optic neuropathy. Graefes Arch Clin Exp Ophthalmol (2008) 0.80
Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES): six-month results of a prospective randomized clinical trial. Acta Ophthalmol (2014) 0.80
Quantification of metamorphopsia in patients with epiretinal membranes before and after surgery. Graefes Arch Clin Exp Ophthalmol (2007) 0.79
Efficacy and Safety of Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema. Ophthalmologica (2015) 0.79
Genotype-phenotype correlations of TGFBI p.Leu509Pro, p.Leu509Arg, p.Val613Gly, and the allelic association of p.Met502Val-p.Arg555Gln mutations. Mol Vis (2011) 0.79
Experimental percutaneous cannulation of the supraorbital arteries: implication for future therapy. Invest Ophthalmol Vis Sci (2005) 0.78
The future of patient safety: Surgical trainees accept virtual reality as a new training tool. Patient Saf Surg (2008) 0.78
Early-onset foveal involvement in retinitis punctata albescens with mutations in RLBP1. JAMA Ophthalmol (2013) 0.78
Massive subhyaloidal hemorrhage associated with severe PAI-1 deficiency. Graefes Arch Clin Exp Ophthalmol (2005) 0.78
Performance on a virtual reality angled laparoscope task correlates with spatial ability of trainees. Indian J Surg (2010) 0.77
Intravitreal ranibizumab versus isovolemic hemodilution in the treatment of macular edema secondary to central retinal vein occlusion: twelve-month results of a prospective, randomized, multicenter trial. Ophthalmologica (2014) 0.77
Dantrolene for severe rhabdomyolysis in Staphylococcus aureus toxic shock syndrome. Eur J Anaesthesiol (2012) 0.77
Congenital neutropenia with retinopathy, a new phenotype without intellectual deficiency or obesity secondary to VPS13B mutations. Am J Med Genet A (2013) 0.77
A novel locus (CORD12) for autosomal dominant cone-rod dystrophy on chromosome 2q24.2-2q33.1. BMC Med Genet (2011) 0.77
Intraocular levels of methotrexate after oral low-dose treatment in chronic uveitis. Ophthalmologica (2005) 0.77
Retinal vein occlusion associated with antithrombin deficiency secondary to a novel G9840C missense mutation. Arch Ophthalmol (2006) 0.77
Cataract as a phenotypic marker for a mutation in WFS1, the Wolfram syndrome gene. Eur J Ophthalmol (2012) 0.76
Selective Thrombophilia Screening in Young Patients with Retinal Artery Occlusion. Ophthalmologica (2016) 0.76
Expression of ubiquitin carboxy-terminal hydrolase-l1 in photocoagulated human retinal pigment epithelial cells. Curr Eye Res (2007) 0.75
Clinical utility gene card for: Achromatopsia - update 2013. Eur J Hum Genet (2013) 0.75
Pigment epithelium endoscopic laser surgery for treatment of choroidal neovascularization. Ophthalmologica (2004) 0.75
[From yeast to neurodegenerative diseases: ten years of exploration of mitochondrial dynamic disorders]. Med Sci (Paris) (2010) 0.75
Dexamethasone Implants in Patients with Naive Diabetic Macular Edema. Ophthalmologica (2016) 0.75
Spatially Resolved Spectral Sensitivities as a Potential Read-out Parameter in Clinical Gene Therapeutic Trials. Ophthalmic Res (2017) 0.75
LEBER CONGENITAL AMAUROSIS WITH LARGE RETINAL PIGMENT CLUMPS CAUSED BY COMPOUND HETEROZYGOUS MUTATIONS IN KCNJ13. Retin Cases Brief Rep (2016) 0.75
Unilateral retinal pigment epithelium dysgenesis. Am J Ophthalmol (2009) 0.75
Cu-Ag (111) polymorphism induced by segregation and advacancies. Phys Rev Lett (2003) 0.75
Screening genes of the visual cycle RGR, RBP1 and RBP3 identifies rare sequence variations. Ophthalmic Genet (2010) 0.75